APA (7th ed.) Citation

Leach, A., Miller, A., Bentley, E., Mattiuzzo, G., Thomas, J., McAndrew, C., . . . Rabbitts, T. (2021). Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins. Scientific Reports, 11(1), 1. https://doi.org/10.1038/s41598-021-89887-w

Chicago Style (17th ed.) Citation

Leach, Adam, Ami Miller, Emma Bentley, Giada Mattiuzzo, Jemima Thomas, Craig McAndrew, Rob Van Montfort, and Terence Rabbitts. "Implementing a Method for Engineering Multivalency to Substantially Enhance Binding of Clinical Trial Anti-SARS-CoV-2 Antibodies to Wildtype Spike and Variants of Concern Proteins." Scientific Reports 11, no. 1 (2021): 1. https://doi.org/10.1038/s41598-021-89887-w.

MLA (9th ed.) Citation

Leach, Adam, et al. "Implementing a Method for Engineering Multivalency to Substantially Enhance Binding of Clinical Trial Anti-SARS-CoV-2 Antibodies to Wildtype Spike and Variants of Concern Proteins." Scientific Reports, vol. 11, no. 1, 2021, p. 1, https://doi.org/10.1038/s41598-021-89887-w.